SCIENCEASIA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2197582, encodeId=b9e8219e582fe, content=ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Tue Apr 09 12:41:03 CST 2024, time=2024-04-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=820236, encodeId=911c82023641, content=审稿速度:1.0 经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Wed Jun 27 14:01:00 CST 2012, time=2012-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185998, encodeId=1a48218599870, content=投稿系统很垃圾，填好第一页进入第二页直接报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62908115958, createdName=ms4000000319256440, createdTime=Mon Feb 05 13:57:18 CST 2024, time=2024-02-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1103070, encodeId=772911030e0b1, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585581, encodeId=f5615855812c, content=这个杂志社作者怎么登陆进去,没有密码?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31cc5196471, createdName=wy15754632309_64371456, createdTime=Sat Feb 29 10:51:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103069, encodeId=c2fb1103069f7, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848934, encodeId=a39d84893440, content=审稿速度:3.0 经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Dec 27 13:41:30 CST 2018, time=2018-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841675, encodeId=e20e8416e554, content=官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Wed Mar 21 01:10:59 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543682, encodeId=6a17543682e9, content=只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lin_ling, createdTime=Fri Jul 14 18:54:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503578, encodeId=04065035e82b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jun 16 13:15:00 CST 2014, time=2014-06-16, status=1, ipAttribution=)]

2024-04-09 ms2000000536781631 来自甘肃省

ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有

70 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197582, encodeId=b9e8219e582fe, content=ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Tue Apr 09 12:41:03 CST 2024, time=2024-04-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=820236, encodeId=911c82023641, content=审稿速度:1.0 经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Wed Jun 27 14:01:00 CST 2012, time=2012-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185998, encodeId=1a48218599870, content=投稿系统很垃圾，填好第一页进入第二页直接报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62908115958, createdName=ms4000000319256440, createdTime=Mon Feb 05 13:57:18 CST 2024, time=2024-02-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1103070, encodeId=772911030e0b1, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585581, encodeId=f5615855812c, content=这个杂志社作者怎么登陆进去,没有密码?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31cc5196471, createdName=wy15754632309_64371456, createdTime=Sat Feb 29 10:51:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103069, encodeId=c2fb1103069f7, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848934, encodeId=a39d84893440, content=审稿速度:3.0 经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Dec 27 13:41:30 CST 2018, time=2018-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841675, encodeId=e20e8416e554, content=官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Wed Mar 21 01:10:59 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543682, encodeId=6a17543682e9, content=只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lin_ling, createdTime=Fri Jul 14 18:54:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503578, encodeId=04065035e82b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jun 16 13:15:00 CST 2014, time=2014-06-16, status=1, ipAttribution=)]

2012-06-27 ms2798897682501839

审稿速度:1.0
经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。

115 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197582, encodeId=b9e8219e582fe, content=ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Tue Apr 09 12:41:03 CST 2024, time=2024-04-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=820236, encodeId=911c82023641, content=审稿速度:1.0 经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Wed Jun 27 14:01:00 CST 2012, time=2012-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185998, encodeId=1a48218599870, content=投稿系统很垃圾，填好第一页进入第二页直接报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62908115958, createdName=ms4000000319256440, createdTime=Mon Feb 05 13:57:18 CST 2024, time=2024-02-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1103070, encodeId=772911030e0b1, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585581, encodeId=f5615855812c, content=这个杂志社作者怎么登陆进去,没有密码?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31cc5196471, createdName=wy15754632309_64371456, createdTime=Sat Feb 29 10:51:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103069, encodeId=c2fb1103069f7, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848934, encodeId=a39d84893440, content=审稿速度:3.0 经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Dec 27 13:41:30 CST 2018, time=2018-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841675, encodeId=e20e8416e554, content=官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Wed Mar 21 01:10:59 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543682, encodeId=6a17543682e9, content=只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lin_ling, createdTime=Fri Jul 14 18:54:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503578, encodeId=04065035e82b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jun 16 13:15:00 CST 2014, time=2014-06-16, status=1, ipAttribution=)]

2024-02-05 ms4000000319256440 来自浙江省

投稿系统很垃圾，填好第一页进入第二页直接报错

57 0

[GetPortalCommentsPageByObjectIdResponse(id=2197582, encodeId=b9e8219e582fe, content=ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Tue Apr 09 12:41:03 CST 2024, time=2024-04-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=820236, encodeId=911c82023641, content=审稿速度:1.0 经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Wed Jun 27 14:01:00 CST 2012, time=2012-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185998, encodeId=1a48218599870, content=投稿系统很垃圾，填好第一页进入第二页直接报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62908115958, createdName=ms4000000319256440, createdTime=Mon Feb 05 13:57:18 CST 2024, time=2024-02-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1103070, encodeId=772911030e0b1, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585581, encodeId=f5615855812c, content=这个杂志社作者怎么登陆进去,没有密码?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31cc5196471, createdName=wy15754632309_64371456, createdTime=Sat Feb 29 10:51:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103069, encodeId=c2fb1103069f7, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848934, encodeId=a39d84893440, content=审稿速度:3.0 经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Dec 27 13:41:30 CST 2018, time=2018-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841675, encodeId=e20e8416e554, content=官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Wed Mar 21 01:10:59 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543682, encodeId=6a17543682e9, content=只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lin_ling, createdTime=Fri Jul 14 18:54:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503578, encodeId=04065035e82b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jun 16 13:15:00 CST 2014, time=2014-06-16, status=1, ipAttribution=)]

2021-12-29 MS54455111222

如果文章发表了未提供ORCIDID如何添加？

81 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197582, encodeId=b9e8219e582fe, content=ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Tue Apr 09 12:41:03 CST 2024, time=2024-04-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=820236, encodeId=911c82023641, content=审稿速度:1.0 经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Wed Jun 27 14:01:00 CST 2012, time=2012-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185998, encodeId=1a48218599870, content=投稿系统很垃圾，填好第一页进入第二页直接报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62908115958, createdName=ms4000000319256440, createdTime=Mon Feb 05 13:57:18 CST 2024, time=2024-02-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1103070, encodeId=772911030e0b1, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585581, encodeId=f5615855812c, content=这个杂志社作者怎么登陆进去,没有密码?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31cc5196471, createdName=wy15754632309_64371456, createdTime=Sat Feb 29 10:51:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103069, encodeId=c2fb1103069f7, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848934, encodeId=a39d84893440, content=审稿速度:3.0 经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Dec 27 13:41:30 CST 2018, time=2018-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841675, encodeId=e20e8416e554, content=官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Wed Mar 21 01:10:59 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543682, encodeId=6a17543682e9, content=只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lin_ling, createdTime=Fri Jul 14 18:54:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503578, encodeId=04065035e82b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jun 16 13:15:00 CST 2014, time=2014-06-16, status=1, ipAttribution=)]

2020-02-29 wy15754632309_64371456

这个杂志社作者怎么登陆进去,没有密码?

143 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197582, encodeId=b9e8219e582fe, content=ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Tue Apr 09 12:41:03 CST 2024, time=2024-04-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=820236, encodeId=911c82023641, content=审稿速度:1.0 经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Wed Jun 27 14:01:00 CST 2012, time=2012-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185998, encodeId=1a48218599870, content=投稿系统很垃圾，填好第一页进入第二页直接报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62908115958, createdName=ms4000000319256440, createdTime=Mon Feb 05 13:57:18 CST 2024, time=2024-02-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1103070, encodeId=772911030e0b1, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585581, encodeId=f5615855812c, content=这个杂志社作者怎么登陆进去,没有密码?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31cc5196471, createdName=wy15754632309_64371456, createdTime=Sat Feb 29 10:51:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103069, encodeId=c2fb1103069f7, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848934, encodeId=a39d84893440, content=审稿速度:3.0 经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Dec 27 13:41:30 CST 2018, time=2018-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841675, encodeId=e20e8416e554, content=官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Wed Mar 21 01:10:59 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543682, encodeId=6a17543682e9, content=只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lin_ling, createdTime=Fri Jul 14 18:54:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503578, encodeId=04065035e82b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jun 16 13:15:00 CST 2014, time=2014-06-16, status=1, ipAttribution=)]

2021-12-28 ms6000000264964247

如何判断两种药物之间是协同作用还是相加作用？

81 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197582, encodeId=b9e8219e582fe, content=ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Tue Apr 09 12:41:03 CST 2024, time=2024-04-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=820236, encodeId=911c82023641, content=审稿速度:1.0 经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Wed Jun 27 14:01:00 CST 2012, time=2012-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185998, encodeId=1a48218599870, content=投稿系统很垃圾，填好第一页进入第二页直接报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62908115958, createdName=ms4000000319256440, createdTime=Mon Feb 05 13:57:18 CST 2024, time=2024-02-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1103070, encodeId=772911030e0b1, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585581, encodeId=f5615855812c, content=这个杂志社作者怎么登陆进去,没有密码?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31cc5196471, createdName=wy15754632309_64371456, createdTime=Sat Feb 29 10:51:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103069, encodeId=c2fb1103069f7, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848934, encodeId=a39d84893440, content=审稿速度:3.0 经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Dec 27 13:41:30 CST 2018, time=2018-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841675, encodeId=e20e8416e554, content=官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Wed Mar 21 01:10:59 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543682, encodeId=6a17543682e9, content=只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lin_ling, createdTime=Fri Jul 14 18:54:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503578, encodeId=04065035e82b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jun 16 13:15:00 CST 2014, time=2014-06-16, status=1, ipAttribution=)]

2018-12-27 ms5663569584175544

审稿速度:3.0
经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了.

132 0

[GetPortalCommentsPageByObjectIdResponse(id=2197582, encodeId=b9e8219e582fe, content=ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Tue Apr 09 12:41:03 CST 2024, time=2024-04-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=820236, encodeId=911c82023641, content=审稿速度:1.0 经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Wed Jun 27 14:01:00 CST 2012, time=2012-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185998, encodeId=1a48218599870, content=投稿系统很垃圾，填好第一页进入第二页直接报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62908115958, createdName=ms4000000319256440, createdTime=Mon Feb 05 13:57:18 CST 2024, time=2024-02-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1103070, encodeId=772911030e0b1, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585581, encodeId=f5615855812c, content=这个杂志社作者怎么登陆进去,没有密码?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31cc5196471, createdName=wy15754632309_64371456, createdTime=Sat Feb 29 10:51:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103069, encodeId=c2fb1103069f7, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848934, encodeId=a39d84893440, content=审稿速度:3.0 经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Dec 27 13:41:30 CST 2018, time=2018-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841675, encodeId=e20e8416e554, content=官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Wed Mar 21 01:10:59 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543682, encodeId=6a17543682e9, content=只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lin_ling, createdTime=Fri Jul 14 18:54:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503578, encodeId=04065035e82b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jun 16 13:15:00 CST 2014, time=2014-06-16, status=1, ipAttribution=)]

2018-03-21 ms887994580797846

官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。

128 0

[GetPortalCommentsPageByObjectIdResponse(id=2197582, encodeId=b9e8219e582fe, content=ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Tue Apr 09 12:41:03 CST 2024, time=2024-04-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=820236, encodeId=911c82023641, content=审稿速度:1.0 经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Wed Jun 27 14:01:00 CST 2012, time=2012-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185998, encodeId=1a48218599870, content=投稿系统很垃圾，填好第一页进入第二页直接报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62908115958, createdName=ms4000000319256440, createdTime=Mon Feb 05 13:57:18 CST 2024, time=2024-02-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1103070, encodeId=772911030e0b1, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585581, encodeId=f5615855812c, content=这个杂志社作者怎么登陆进去,没有密码?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31cc5196471, createdName=wy15754632309_64371456, createdTime=Sat Feb 29 10:51:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103069, encodeId=c2fb1103069f7, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848934, encodeId=a39d84893440, content=审稿速度:3.0 经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Dec 27 13:41:30 CST 2018, time=2018-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841675, encodeId=e20e8416e554, content=官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Wed Mar 21 01:10:59 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543682, encodeId=6a17543682e9, content=只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lin_ling, createdTime=Fri Jul 14 18:54:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503578, encodeId=04065035e82b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jun 16 13:15:00 CST 2014, time=2014-06-16, status=1, ipAttribution=)]

2017-07-14 Lin_ling

只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore

358 0

[GetPortalCommentsPageByObjectIdResponse(id=2197582, encodeId=b9e8219e582fe, content=ScienceAsia 投稿第一天中了肯定更新没更新就是没录投稿后就发了邮件，给了编号登录账号都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Tue Apr 09 12:41:03 CST 2024, time=2024-04-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=820236, encodeId=911c82023641, content=审稿速度:1.0 经验分享：审稿比较规范，编辑处理稿件速度非常快、录用后马上就会出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Wed Jun 27 14:01:00 CST 2012, time=2012-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185998, encodeId=1a48218599870, content=投稿系统很垃圾，填好第一页进入第二页直接报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62908115958, createdName=ms4000000319256440, createdTime=Mon Feb 05 13:57:18 CST 2024, time=2024-02-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1103070, encodeId=772911030e0b1, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585581, encodeId=f5615855812c, content=这个杂志社作者怎么登陆进去,没有密码?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31cc5196471, createdName=wy15754632309_64371456, createdTime=Sat Feb 29 10:51:00 CST 2020, time=2020-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103069, encodeId=c2fb1103069f7, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848934, encodeId=a39d84893440, content=审稿速度:3.0 经验分享：刚投了，但是期刊主页只发布了18年8月文章，后续没更新，这个期刊是不是不办了？我打算重新投了. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Dec 27 13:41:30 CST 2018, time=2018-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841675, encodeId=e20e8416e554, content=官网投稿首页填好后无法进入下一步操作，求最新投稿页面链接。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d445414141, createdName=ms887994580797846, createdTime=Wed Mar 21 01:10:59 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543682, encodeId=6a17543682e9, content=只要能保住SCI源的期刊,就可以了.以后学校采用CiteScore来计算的话,就不用怕了. 一方面CiteScore引用的杂志宽得多,这个杂志肯定在其中,另外,对小杂志有好处,大家差剧没这么大, 希望学校采用CiteScore, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Lin_ling, createdTime=Fri Jul 14 18:54:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503578, encodeId=04065035e82b, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jun 16 13:15:00 CST 2014, time=2014-06-16, status=1, ipAttribution=)]

2014-06-16 匿名用户

审稿速度:3.0 | 投稿命中率:75.0
经验分享：投稿系统比较原始，而且投稿周期很长，我是3月初投稿的，6月中才给审稿意见，而且只有一个审稿人的意见，不过被拒了。

412 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务